RANI

Rani Therapeutics Holdings, Inc. Class A Common Stock

0.75

USD

-0.02

-2.35%

Sep 24, 15:55 UTC -4

Closed

Pre-Market

0.73

-0.02

-2.27%

Rani Therapeutics Holdings, Inc. Class A Common Stock Profile

About

Rani Therapeutics Holdings Inc. is a clinical stage biotherapeutics company. It focused on advancing technologies to enable the development of orally administered biologics. Rani Therapeutics Holdings Inc. is based in SAN JOSE, Calif.

Info & Links

CEO

Talat Imran

Headquarters

2051 RINGWOOD AVENUE
SAN JOSE, CA 95131, UNITED STATES

Auditor

CBIZ CPAS P.C.

Share holders

131

Employees

Rani Therapeutics Holdings, Inc. Class A Common Stock Statistics

Valuation Measures

Market Capitalization²

84.49M

Enterprise Value

79.62M

Enterprise Value/EBITDA(ttm)

-2.43

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

Price to Book(mrq)

2.21

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

75.00%

Operating Margin(ttm)

Profit Margin(ttm)

-387.46%

Return on Equity(ttm)

-104.60%

Return on Invested Capital(ttm)

4.14%

Return on Assets(ttm)

-65.17%

Income Statement

Revenue(ttm)

4.88M

Revenue Per Share(ttm)

0.03

Gross Profit(ttm)

4.88M

EBITDA(ttm)³

-32.78M

Net Income Available to Common(ttm)

-30.14M

Diluted EPS(ttm)

-0.27

Share Statistics

Beta (5Y Monthly)

0.69

52-Week Change

52.86%

S&P 500 52-Week Change

19.38%

S&P 500 Member

Stock Optionable

Yes

Total Shares Outstanding¹

139.40M

Dividend Yield

0.00%

Float⁴

102.14M

% Held by Insiders

26.73%

% Held by Institutions

30.19%

Balance Sheet

Total Cash(mrq)

53.39M

Total Cash Per Share(mrq)

0.38

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

5.31%

Quick Ratio(mrq)

5.31%

Book Value Per Share(mrq)

0.35

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.08

Free Cash Flow(ytd)

-15.57M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.